| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.71B | +0.5% | +4.4% |
| Cost of Revenue | $504.0M | +5.4% | +1.6% |
| Gross Profit | $1.21B | -1.5% | +5.6% |
| R&D Expense | $237.0M | -5.6% | -4.0% |
| SG&A Expense | $86.0M | -3.4% | +16.2% |
| Operating Income | $434.0M | +8.8% | +19.9% |
| Pre-tax Income | $433.0M | +10.2% | +17.0% |
| Income Tax | $99.0M | +12.5% | +39.4% |
| Net Income | $334.0M | +9.5% | +11.7% |
| EPS (Basic) | $1.69 | +10.5% | +15.0% |
| EPS (Diluted) | $1.67 | +10.6% | +16.0% |
| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.63B | -21.4% | +7.8% |
| Short-term Investments | $1.38B | +46.4% | +83.9% |
| Accounts Receivable | $1.31B | +33.0% | +46.3% |
| Inventory | $109.0M | -14.2% | -59.3% |
| Current Assets | $5.00B | +7.3% | +27.8% |
| Total Assets | $9.97B |
| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.12B | — | — |
| Capital Expenditures | $148.0M | — | — |
| Investing Cash Flow | -$415.0M | — | — |
| Financing Cash Flow | -$1.82B | — | — |
| Free Cash Flow | $969.0M | — | — |
| +10.9% |
| Current Liabilities | $3.59B | +3.6% | -14.3% |
| Long-term Debt | $2.49B | +0.0% | +24.7% |
| Total Liabilities | $8.81B | +2.0% | +10.2% |
| Stockholders' Equity | $1.16B | +17.4% | +16.4% |